Get the Stockscreener App
6.36
0.32%
0.02
After Hours:
6.54
0.18
+2.83%
Lifemd Inc stock is traded at $6.36, with a volume of 609.85K.
It is up +0.32% in the last 24 hours and up +48.25% over the past month.
LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.
See More
Previous Close:
$6.34
Open:
$6.43
24h Volume:
609.85K
Relative Volume:
1.10
Market Cap:
$283.26M
Revenue:
$193.06M
Net Income/Loss:
$-22.51M
P/E Ratio:
-6.1154
EPS:
-1.04
Net Cash Flow:
$10.63M
1W Performance:
+17.34%
1M Performance:
+48.25%
6M Performance:
-18.88%
1Y Performance:
-8.23%
1-Day Range:
$6.30
$6.90
1-Week Range:
$5.40
$6.90
52-Week Range:
$3.99
$12.88
Lifemd Inc Stock (LFMD) Company Profile
Name
Lifemd Inc
Sector
Industry
Phone
(866) 351-5907
Address
236 FIFTH AVENUE, NEW YORK
Compare LFMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LFMD
Lifemd Inc
|
6.36 | 283.26M | 193.06M | -22.51M | 10.63M | -1.04 |
|
VEEV
Veeva Systems Inc
|
226.76 | 36.93B | 2.57B | 615.26M | 996.76M | 3.32 |
|
SOLV
Solventum Corp
|
72.48 | 12.43B | 8.26B | 66.00M | 1.17B | 0.00 |
|
TEM
Tempus Ai Inc
|
62.98 | 10.01B | 640.44M | -743.28M | -206.93M | 0.00 |
|
DOCS
Doximity Inc
|
53.39 | 9.94B | 493.63M | 160.55M | 162.20M | 0.55 |
|
HQY
Healthequity Inc
|
102.47 | 8.91B | 1.10B | 105.67M | -197.98M | 0.1475 |
Lifemd Inc Stock (LFMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-23-24 | Resumed | B. Riley Securities | Buy |
| Jun-05-24 | Initiated | KeyBanc Capital Markets | Overweight |
| Nov-30-23 | Initiated | Craig Hallum | Buy |
| Jul-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-03-23 | Initiated | H.C. Wainwright | Buy |
| Mar-10-22 | Initiated | Colliers Securities | Buy |
| Oct-04-21 | Resumed | B. Riley Securities | Buy |
View All
Lifemd Inc Stock (LFMD) Latest News
LifeMD, Inc. (NASDAQ:LFMD) Given Consensus Rating of "Buy" by Analysts - MarketBeat
(LFMD) Technical Data - Stock Traders Daily
Royce & Associates LP Boosts Stock Holdings in LifeMD, Inc. (NASDAQ:LFMD) - MarketBeat
LifeMD (NASDAQ:LFMDP) Stock Price Down 1.1% – Should You Sell? - Defense World
LifeMD, Inc. (NASDAQ:LFMD) Shares Bought by Los Angeles Capital Management LLC - MarketBeat
LifeMD (LFMD) to Present at Three Major Healthcare Investor Conferences in November | LFMDP Stock News - StockTitan
LifeMD to Participate in Three Investor Conferences During November - The Manila Times
LifeMD (LFMD) to Present at Three Major Healthcare Investor Conferences in November | LFMD Stock News - StockTitan
LifeMD Inc (NASDAQ: LFMD) Could Pass $12 In One Year Stock Forecast - Stocks Register
HC Wainwright Reiterates Buy Rating for LifeMD (NASDAQ:LFMD) - MarketBeat
LifeMD, Inc. (NASDAQ:LFMD) Q3 2024 Earnings Call Transcript - Insider Monkey
LifeMD, Inc.'s (NASDAQ:LFMD) Shares Leap 31% Yet They're Still Not Telling The Full Story - Simply Wall St
LifeMD Third Quarter 2024 Earnings: EPS Misses Expectations - Yahoo Finance
(LFMD) Technical Pivots with Risk Controls - Stock Traders Daily
LifeMD Inc (LFMD) Q3 2024 Earnings Call Highlights: Strong Teleh - GuruFocus.com
LifeMD Inc (LFMD) Q3 2024 Earnings Call Highlights: Strong Telehealth Growth and Strategic ... - Yahoo Finance
LifeMD, Inc. (LFMD) Reports Q3 Loss, Lags Revenue Estimates - MSN
LifeMD, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
LifeMD Reports Third Quarter 2024 Results - The Manila Times
LifeMD earnings beat by $0.21, revenue fell short of estimates - Investing.com UK
Institutions profited after LifeMD, Inc.'s (NASDAQ:LFMD) market cap rose US$39m last week but individual investors profited the most - Simply Wall St
Earnings to Watch: LifeMD Inc (LFMD) Reports Q3 2024 Result - GuruFocus.com
LifeMD® Launches Affiliated Pharmacy to Drive End-to-End Patient Care and Operational Efficiency - The Manila Times
Brokerages Set LifeMD, Inc. (NASDAQ:LFMD) Target Price at $12.00 - Defense World
Medifast Announces Third Quarter 2024 Financial Results - StockTitan
LifeMD, Inc. (NASDAQ:LFMD) Given Average Rating of "Buy" by Brokerages - MarketBeat
LifeMD announces board member resignation By Investing.com - Investing.com Australia
LifeMD announces board member resignation - Investing.com India
LifeMD stock touches 52-week low at $4.03 amid market challenges - Investing.com Canada
LifeMD (LFMD) Set to Announce Earnings on Thursday - MarketBeat
LifeMD Shares Decline Even After the Launch of Testosterone Therapy - MSN
LifeMD® To Report Third Quarter 2024 Financial Results On November 7 - Barchart
LifeMD launches TestoRx, direct to consumer testosterone replacement therapy - Yahoo Finance
LifeMD® to Report Third Quarter 2024 Financial Results on November 7 - GlobeNewswire
LifeMD® Launches TestoRx, a New Rex MD® Direct-to-Consumer - GlobeNewswire
LifeMD® Launches TestoRx, a New Rex MD® Direct-to-Consumer Testosterone Replacement Therapy Telehealth Offering - Yahoo Finance
The Manufacturers Life Insurance Company Purchases Shares of 13,551 LifeMD, Inc. (NASDAQ:LFMD) - Defense World
Trading Day Review: LifeMD Inc (LFMD) Gains Momentum, Closing at 4.64 - The Dwinnex
LifeMD shares hold as BTIG maintains $12 target By Investing.com - Investing.com Australia
LifeMD shares hold as BTIG maintains $12 target - Investing.com
Is it possible to buy LifeMD Inc(LFMD) shares at a good price now? - US Post News
LifeMD, Inc.'s (NASDAQ:LFMD) top owners are retail investors with 45% stake, while 38% is held by institutions - Yahoo Finance
LifeMD Inc [LFMD] stock for 14,790 USD was bought by Galluppi Stefan - Knox Daily
LifeMD Inc (LFMD) Stock: A Year of Declines and Increases - The InvestChronicle
Financial Health Check: Examining LifeMD Inc (LFMD)’s Key Ratios - The Dwinnex
LifeMD shares maintain Buy rating from B.Riley amid market demand By Investing.com - Investing.com South Africa
Lifemd Inc Stock (LFMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.88%
1.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):